These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 31942640)

  • 1. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What did we learn from multiple omics studies in asthma?
    Ivanova O; Richards LB; Vijverberg SJ; Neerincx AH; Sinha A; Sterk PJ; Maitland-van der Zee AH
    Allergy; 2019 Nov; 74(11):2129-2145. PubMed ID: 31004501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Asthma: Dissecting the Role of Metabolomics, Genomics and Personalized Medicine.
    Bush A
    Indian J Pediatr; 2018 Aug; 85(8):643-650. PubMed ID: 29185231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm.
    Gautam Y; Johansson E; Mersha TB
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical challenges in omics research on asthma and allergy: A National Institute of Allergy and Infectious Diseases workshop.
    Bunyavanich S; Becker PM; Altman MC; Lasky-Su J; Ober C; Zengler K; Berdyshev E; Bonneau R; Chatila T; Chatterjee N; Chung KF; Cutcliffe C; Davidson W; Dong G; Fang G; Fulkerson P; Himes BE; Liang L; Mathias RA; Ogino S; Petrosino J; Price ND; Schadt E; Schofield J; Seibold MA; Steen H; Wheatley L; Zhang H; Togias A; Hasegawa K
    J Allergy Clin Immunol; 2024 Apr; 153(4):954-968. PubMed ID: 38295882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food allergy and omics.
    Dhondalay GK; Rael E; Acharya S; Zhang W; Sampath V; Galli SJ; Tibshirani R; Boyd SD; Maecker H; Nadeau KC; Andorf S
    J Allergy Clin Immunol; 2018 Jan; 141(1):20-29. PubMed ID: 29307411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omics technologies in allergy and asthma research: An EAACI position paper.
    Radzikowska U; Baerenfaller K; Cornejo-Garcia JA; Karaaslan C; Barletta E; Sarac BE; Zhakparov D; Villaseñor A; Eguiluz-Gracia I; Mayorga C; Sokolowska M; Barbas C; Barber D; Ollert M; Chivato T; Agache I; Escribese MM
    Allergy; 2022 Oct; 77(10):2888-2908. PubMed ID: 35713644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics sciences and precision medicine in melanoma.
    Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood asthma in the new omics era: challenges and perspectives.
    Golebski K; Kabesch M; Melén E; Potočnik U; van Drunen CM; Reinarts S; Maitland-van der Zee AH; Vijverberg SJH;
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):155-161. PubMed ID: 31985545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
    Banerjee S; Prabhu Basrur N; Rai PS
    Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omics sciences and precision medicine in Urothelial Carcinoma.
    Medori MC; Micheletti C; Madeo G; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Ahmed R; Ahmed R; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):1-10. PubMed ID: 37994743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for "Omics" Technology?
    Galeone C; Scelfo C; Bertolini F; Caminati M; Ruggiero P; Facciolongo N; Menzella F
    Biomed Res Int; 2018; 2018():4617565. PubMed ID: 29992143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of omics technologies in dermatological research and skin management.
    He J; Jia Y
    J Cosmet Dermatol; 2022 Feb; 21(2):451-460. PubMed ID: 33759323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
    Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
    Front Immunol; 2018; 9():2727. PubMed ID: 30631320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
    Ahmed Z
    Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 52.